Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Al Hebshi, Nezar Noor ^a,b   Nasher, Akram Thabet ^c   Maryoud, Mohamed Yousef ^a   Homeida, Husham E ^a   Chen, Tsute ^d   Idris, Ali Mohamed ^a   Johnson, Newell W ^e  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b TEMPLE UNIVERSITY   (United States)

^c SANA A UNIVERSITY   (Yemen)

^d FORSYTH INSTITUTE   (United States)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIODIVERSITY; CASE CONTROL STUDY; CLASSIFICATION; COMPLICATION; FEMALE; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; GENETICS; HUMAN; MALE; METAGENOME; METAGENOMICS; MICROBIOLOGY; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROCEDURES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIODIVERSITY; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; HUMANS; MALE; METAGENOME; METAGENOMICS; MIDDLE AGED; MOUTH NEOPLASMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 85019243015     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02079-3     Document Type: Article

References (56)

1. Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] http://globocan.iarc.fr (2013).
2. Wang, B., Zhang, S., Yue, K. & Wang, X. D. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer 32, 614-618, doi: 10.5732/cjc.012.10219 (2013).
3. Sklenicka, S., Gardiner, S., Dierks, E. J., Potter, B. E. & Bell, R. B. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome? J Oral Maxillofac Surg 68, 1270-1275, doi: 10.1016/j.joms.2009.11.016 (2010).
4. Petti, S. Lifestyle risk factors for oral cancer. Oral Oncol 45, 340-350, doi: 10.1016/j.oraloncology.2008.05.018 (2009).
5. Gupta, B., Johnson, N. W. & Kumar, N. Global Epidemiology of Head and Neck Cancers: A Continuing Challenge. Oncology 91, 13-23, doi: 10.1159/000446117 (2016).
6. Chocolatewala, N., Chaturvedi, P. & Desale, R. The role of bacteria in oral cancer. Indian J Med Paediatr Oncol 31, 126-131, doi: 10.4103/0971-5851.76195 (2010).
7. Perera, M., Al-Hebshi, N. N., Speicher, D. J., Perera, I. & Johnson, N. W. Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria. J Oral Microbiol 8, 32762, doi: 10.3402/jom.v8.32762 (2016).
8. Hooper, S. J. et al. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol 44, 1719-1725, doi: 10.1128/JCM.44.5.1719-1725.2006 (2006).
9. Hooper, S. J. et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol 56, 1651-1659, doi: 10.1099/jmm.0.46918-0 (2007).
10. Al-Hebshi, N. N., Nasher, A. T., Idris, A. M. & Chen, T. Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples. J Oral Microbiol 7, 28934, doi: 10.3402/jom.v7.28934 (2015).
11. Guerrero-Preston, R. et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, Human Papilloma Virus infection and surgical treatment. Oncotarget (2016).
12. Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I. & Cha, S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci 3, 209-215, doi: 10.4248/IJOS11075 (2011).
13. Mager, D. L. et al. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3, 27, doi: 10.1186/1479-5876-3-27 (2005).
14. Morita, E. et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci 94, 492-496, doi: 10.1111/cas.2003.94.issue-6 (2003).
15. Nagy, K. N., Sonkodi, I., Szoke, I., Nagy, E. & Newman, H. N. The microflora associated with human oral carcinomas. Oral Oncol 34, 304-308, doi: 10.1016/S1368-8375(98)80012-2 (1998).
16. Pushalkar, S. et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 12, 144, doi: 10.1186/1471-2180-12-144 (2012).
17. Pushalkar, S. et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 61, 269-277, doi: 10.1111/j.1574-695X.2010.00773.x (2011).
18. Sasaki, M. et al. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis 11, 151-156, doi: 10.1111/j.1601-0825.2005.01051.x (2005).
19. Schmidt, B. L. et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS One 9, e98741, doi: 10.1371/journal.pone.0098741 (2014).
20. Tateda, M. et al. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med 6, 699-703, doi: 10.3892/ijmm (2000).
21. Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480-484, doi: 10.1038/nature07540 (2009).
22. Siqueira, J. F. Jr., Fouad, A. F. & Rocas, I. N. Pyrosequencing as a tool for better understanding of human microbiomes. J Oral Microbiol 4 (2012).
23. Schloss, P. D. & Westcott, S. L. Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Appl Environ Microbiol 77, 3219-3226, doi: 10.1128/AEM.02810-10 (2011).
24. Nasher, A. T., Al-Hebshi, N. N., Al-Moayad, E. E. & Suleiman, A. M. Viral infection and oral habits as risk factors for oral squamous cell carcinoma in Yemen: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol 118, 566-572 e561 (2014).
25. Al-Hebshi, N. N., Alharbi, F. A., Mahri, M. & Chen, T. Differences in the bacteriome of smokeless tobacco products with different oral carcinogenicity: compositional and predicted functional analysis. Genes 8, 106, doi: 10.3390/genes8040106 (2017).
26. Frank, J. A. et al. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol 74, 2461-2470, doi: 10.1128/AEM.02272-07 (2008).
27. Lane, D. J. et al. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci USA 82, 6955-6959, doi: 10.1073/pnas.82.20.6955 (1985).
28. Zhang, J., Kobert, K., Flouri, T. & Stamatakis, A. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30, 614-620, doi: 10.1093/bioinformatics/btt593 (2014).
29. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537-7541, doi: 10.1128/AEM.01541-09 (2009).
30. Pruesse, E. et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 35, 7188-7196, doi: 10.1093/nar/gkm864 (2007).
31. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200, doi: 10.1093/bioinformatics/btr381 (2011).
32. Schloss, P. D., Gevers, D. & Westcott, S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6, e27310, doi: 10.1371/journal.pone.0027310 (2011).
33. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461, doi: 10.1093/bioinformatics/btq461 (2010).
34. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat methods 7, 335-336, doi: 10.1038/nmeth.f.303 (2010).
35. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, doi: 10.1186/gb-2011-12-6-r60 (2011).
36. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31, 814-821, doi: 10.1038/nbt.2676 (2013).
37. Sawair, F. A. et al. High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background. Int J Environ Health Res 17, 185-195, doi: 10.1080/09603120701254813 (2007).
38. Brown, A., Ravichandran, K. & Warnakulasuriya, S. The unequal burden related to the risk of oral cancer in the different regions of the Kingdom of Saudi Arabia. Community Dent Health 23, 101-106 (2006).
39. Salem, G., Juhl, R. & Schiodt, T. Oral malignant and premalignant changes in 'Shammah'-users from the Gizan region, Saudi Arabia. Acta Odontol Scand 42, 41-45, doi: 10.3109/00016358409041130 (1984).
40. Allard, W. F., DeVol, E. B. & Te, O. B. Smokeless tobacco (shamma) and oral cancer in Saudi Arabia. Community Dent Oral Epidemiol 27, 398-405, doi: 10.1111/com.1999.27.issue-6 (1999).
41. Al-Hebshi, N. N., Abdulhaq, A., Albarrag, A., Basode, V. K. & Chen, T. Species-level core oral bacteriome identified by 16S rRNA pyrosequencing in a healthy young Arab population. J Oral Microbiol 8, 31444, doi: 10.3402/jom.v8.31444 (2016).
42. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22, 292-298, doi: 10.1101/gr.126573.111 (2012).
43. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22, 299-306, doi: 10.1101/gr.126516.111 (2012).
44. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell host & microbe 14, 195-206, doi: 10.1016/j.chom.2013.07.012 (2013).
45. Uitto, V. J. et al. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun 73, 1171-1179, doi: 10.1128/IAI.73.2.1171-1179.2005 (2005).
46. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215, doi: 10.1016/j.chom.2013.07.007 (2013).
47. Binder Gallimidi, A. et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 6, 22613-22623, doi: 10.18632/oncotarget.4209 (2015).
48. Markou, P. & Apidianakis, Y. Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer. Front Cell Infect Microbiol 3, 115, doi: 10.3389/fcimb.2013.00115 (2014).
49. Elsen, S., Collin-Faure, V., Gidrol, X. & Lemercier, C. The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells. Cell Mol Life Sci 70, 4385-4397, doi: 10.1007/s00018-013-1392-3 (2013).
50. Gellatly, S. L. & Hancock, R. E. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67, 159-173, doi: 10.1111/2049-632X.12033 (2013).
51. de Lima, C. D. et al. ExoU activates NF-kappaB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS One 7, e41772, doi: 10.1371/journal.pone.0041772 (2012).
52. Kirst, M. E. et al. Dysbiosis and alterations in predicted functions of the subgingival microbiome in chronic periodontitis. Appl Environ Microbiol 81, 783-793, doi: 10.1128/AEM.02712-14 (2015).
53. Ikebe, M. et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J Surg Oncol 100, 725-731, doi: 10.1002/jso.21392 (2009).
54. Li, S. et al. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway. Mol Med Rep 11, 4454-4462, doi: 10.3892/mmr.2015.3258 (2015).
55. Hsu, R. Y. et al. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis. Cancer Res 71, 1989-1998, doi: 10.1158/0008-5472.CAN-10-2833 (2011).
56. Williams, S. M. et al. Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun 75, 3747-3757, doi: 10.1128/IAI.00082-07 (2007).